Loss of natural killer cell activity in patients with coronary artery disease

Atherosclerosis

Volumn 183, Issue 2, 2005, Pages 316-321

  Jonasson, Lena ^a,b   Backteman, Karin ^a   Ernerudh, Jan ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Coronary disease; Inflammation; Natural killer cells

Indexed keywords

ACETYLSALICYLIC ACID; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CD56 ANTIGEN; CLOPIDOGREL; LOW MOLECULAR WEIGHT HEPARIN; SIMVASTATIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CELL ACTIVITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; INFLAMMATION; LOW DRUG DOSE; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; METABOLISM; NATURAL KILLER CELL; PRIORITY JOURNAL; STABLE ANGINA PECTORIS;

C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, NATURAL; INTERLEUKIN-6; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 27644453448     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.03.011     Document Type: Article

References (32)

1. G.K. Hansson, P. Libby, U. Schönbeck, and Z.-Q. Yan Innate and adaptive immunity in the pathogenesis of atherosclerosis Circ Res 91 2002 281 291
2. L. Jonasson, C. Linderfalk, J. Olsson, A. Wikby, and A.G. Olsson Systemic T cell activation in stable angina pectoris Am J Cardiol 89 2002 4 6
3. G. Liuzzo, J.J. Goronzy, and H. Yang Monoclonal T cell proliferation and plaque instability in acute coronary syndromes Circulation 102 2000 2883 2888
4. G. Caligiuri, G. Paulsson, A. Nivoletti, A. Maseri, and G.K. Hansson Evidence for antigen-driven T cell response in unstable angina Circulation 102 2000 1114 1119
5. S. Stemme, B. Faber, and J. Holm T lymphocytes from human atherosclerotic plaques recognize oxidized low-density lipoprotein Proc Natl Acad Sci USA 92 1995 3893 3897
6. W. Palinski, and J.L. Witztum Immune response to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis J Intern Med 247 2000 371 380
7. P. Saikku, M. Leinonen, and K. Mattila Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction Lancet 2 1988 1196 1197
8. J.B. Muhlestein, B.D. Horne, and J.F. Carlquist Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease Circulation 102 2000 1917 1923
9. A. Kol, and P. Libby The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations Trends Cardiovasc Med 8 1998 191 199
10. M.A. Cooper, T.A. Fehniger, and M.A. Caligiuri The biology of human natural killer-cell subsets Trends Immunol 22 2001 633 640
11. F.E. Munschauer, L.A. Hartrich, C.C. Stewart, and L. Jacobs Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls J Neuroimmunol 62 1995 177 181
12. V. Rccieri, A. Sadaro, and G. Prisi Down-regulation of natural killer cells and of γ/δ T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity? Lupus 9 2000 333 337
13. A.L. Cameron, B. Kirby, and CE.M. Griffiths Circulating natural killer cells in psoriasis Br J Dermatol 149 2003 160 164
14. M.M. Fort, M.W. Leach, and D.M. Rennick A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis J Immunol 161 1998 3256 3261
15. R.B. Smelz, N.A. Wolf, and R.H. Swanborg Inhibition of autoimmune T cell responses in the DA rat by bone marrow-derived NK cells in vitro: implications for autoimmunity J Immunol 163 1999 1390 1397
16. beige mutations Arterioscler Thromb Vasc Biol 22 2002 1341 1346
17. S.C. Whitman, D.L. Rateri, S.J. Szilvassy, W. Yokoyama, and A. Daugherty Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice Arterioscler Thromb Vasc Biol 24 2004 1049 1054
18. E. Svenungsson, K. Jensen-Urstad, and M. Heimburger Risk factors for cardiovascular disease in systemic lupus erythematosus Circulation 104 2001 1887 1893
19. F. Erkeller-Yuksel, F. Hulstaart, I. Hannet, D. Isenberg, and P. Lydyard Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus Lupus 2 1993 227 231
20. F. Erkeller-Yuksel, P. Lydyard, and D. Isenberg Lack of NK cells in lupus patients with renal involvement Lupus 6 1997 708 712
21. Halcox JPJ, and J.E. Deanfield Beyond the laboratory: clinical implications for statin pleiotropy Circulation 109 2004 II42 II48
22. S. Katznelson, A.H. Wilkinson, and J.A. Kobashigawa The effect of pravastatin on acute rejection after kidney transplantation: a pilot study Transplantation 61 1996 1469 1474
23. D.Z. Hillyard, Cameron AJM, and K.J. McDonald Simvastatin inhibits lymphocyte function in normal subjects and patients with cardiovascular disease Atherosclerosis 175 2004 305 313
24. R.J. Benschop, E.E. Nieuwenhuis, and E.A. Tromp Effects of beta-adrenergic blockade on immunologic and cardiovascular changes induced by mental stress Circulation 2 1994 762 769
25. dim natural killer cell subset in patients with cancer Eur J Immunol 33 2003 119 124
26. J.M. McCord The evolution of free radicals and oxidative stress Am J Med 108 2000 652 659
27. T. Weinbrunner, M. Cladellas, and M.I. Covas High oxidative stress in patients with stable coronary artery disease Atherosclerosis 168 2003 99 106
28. K. Nakamura, and K. Matsunaga Susceptibility of natural killer (NK) cells to reactive oxygen species (ROS) and their restoration by the mimics of superoxide dismutase (SOD) Cancer Biother Radiopharm 13 1998 275 290
29. M. Viora, M.G. Quaranta, and E. Straface Redox imbalance and immune functions: opposite effects of oxidized low-density lipoproteins and N-acetylcysteine Immunology 104 2001 431 438
30. K. Takahashi, S. Miyake, and T. Kondo Natural killer type 2 bias in remission of multiple sclerosis J Clin Invest 107 2001 R23 R29
31. K. Ogata, E. An, and Y. Shioi Association between natural killer cell activity and infection in immunologically normal elderly people Clin Exp Immunol 124 2001 392 397
32. H. Bruunsgaard, A.N. Pedersen, M. Schroll, P. Skinhoj, and B. Pedersen Decreased natural killer cell activity is associated with atherosclerosis in elderly humans Exp Gerontol 37 2001 127 136